| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | A Miyoshi | |
| S C Oliveira | |||
| V Azevedo | |||
| A M Goes | |||
| A L Cândido | |||
| G Levitus | |||
| P2860 | cites work | Specific cellular and humoral immune response in Balb/c mice immunised with an expression genomic library of Trypanosoma cruzi. | Q32065484 |
| Protection against mycoplasma infection using expression-library immunization | Q34296157 | ||
| CpG motifs in bacterial DNA trigger direct B-cell activation | Q34307394 | ||
| Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project | Q34311043 | ||
| Immunostimulatory DNA sequences necessary for effective intradermal gene immunization | Q34384185 | ||
| Promoter-regulatory region of the major immediate early gene of human cytomegalovirus | Q36252923 | ||
| Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major | Q36380692 | ||
| The cytomegalovirus enhancer: a pan-active control element in transgenic mice | Q36722124 | ||
| Efficiency of utilization of the simian virus 40 late polyadenylation site: effects of upstream sequences | Q36761958 | ||
| Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs | Q36796132 | ||
| Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo | Q37300317 | ||
| Introns increase transcriptional efficiency in transgenic mice | Q37486009 | ||
| Do the poly(A) tail and 3' untranslated region control mRNA translation? | Q37591951 | ||
| Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells | Q38334274 | ||
| Intervening sequences increase efficiency of RNA 3' processing and accumulation of cytoplasmic RNA | Q40514288 | ||
| Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter | Q41286241 | ||
| Immune responses to nucleic acid vaccines to rabies virus | Q41337967 | ||
| Activity assays of nine heterogeneous promoters in neural and other cultured cells | Q41470524 | ||
| Plasmid DNA expression systems for the purpose of immunization | Q41629004 | ||
| Heterologous protection against influenza by injection of DNA encoding a viral protein | Q43828996 | ||
| Tetracycline-regulated gene expression following direct gene transfer into mouse skeletal muscle | Q45875418 | ||
| An improved plasmid DNA expression vector for direct injection into skeletal muscle | Q45878158 | ||
| Development of improved vectors for DNA-based immunization and other gene therapy applications | Q45882860 | ||
| Myosin regulatory elements as vectors for gene transfer by intramuscular injection | Q45887609 | ||
| Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use. | Q48037076 | ||
| A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus | Q48378635 | ||
| Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction | Q56907798 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 147-153 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | Brazilian Journal of Medical and Biological Research | Q2025772 |
| P1476 | title | Main features of DNA-based immunization vectors | |
| P478 | volume | 32 |
| Q30819471 | Enhanced cell-mediated IFN-gamma-secreting activity against the HIV-1IIIB V3 peptide of the TAB9 multiepitope after DNA vaccine backbone engineering |
| Q24814935 | Ensuring safety of DNA vaccines |
| Q35623329 | Immunological analysis of a Lactococcus lactis-based DNA vaccine expressing HIV gp120. |
| Q34506877 | Improvement of different vaccine delivery systems for cancer therapy |
| Q52949444 | Modulating gene expression using DNA vaccines with different 3'-UTRs influences antibody titer, seroconversion and cytokine profiles. |
| Q35791186 | Nonviral DNA vectors for immunization and therapy: design and methods for their obtention |
Search more.